| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B | $2.2B | $2.2B | $1.2B | $0.9B | $0.5B | $0.2B | $0.0B |
| Cost of Revenue | $0.2B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.1B | $0.2B | $0.5B | $0.7B | $-0.3B | $0.7B | $0.4B | $-0.2B |
| EPS (Basic) | $430.14 | $89.79 | $198.60 | $276.96 | $-89.46 | $157.70 | $19.12 | $-43.24 |
| EPS (Diluted) | $430.14 | $89.79 | $198.60 | $276.96 | $-89.46 | $157.70 | $19.12 | $-43.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.3B | $9.9B | $8.4B | $7.4B | $7.0B | $4.8B | $4.0B | $3.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.2B | $0.1B |
| Total Liabilities | $6.1B | $4.8B | $3.8B | $3.5B | $3.3B | $1.0B | $0.8B | $0.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.4B | $4.5B | $4.2B | $3.7B | $3.5B | $3.9B | $3.3B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.4B | $0.4B | $0.0B | $-0.1B | $-0.1B | $-0.0B |
| Investing Cash Flow | $-0.7B | $-0.4B | $-0.5B | $0.1B | $-0.2B | $0.1B | $-0.1B | $0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.0B | $0.0B | $0.0B | $-0.3B | $0.2B | $0.0B | $0.2B | $-0.4B |